ESC

That Douchebag Who Raised An AIDS Drug 5000% Just Paid $2 Million for Wu-Tang Clan’s Record

Y’all might remember Martin Shkreli. He’s the heartless swine who used his drug startup, Turing Pharmaceuticals, to buy the rights to an AIDS drug called Daraprim. Here’s what the drug does.

Daraprim is used to prevent malaria and treat toxoplasmosis, a parasitic infection that’s especially dangerous to the unborn children of pregnant women and people with weakened immune systems, such as those with AIDS and patients undergoing chemotherapy.

Once he bought the marketing rights to the drug, he turned around and raised the prices from $13.50 a pill to $750.

Eventually, the public backlash forced Shkreli to back off the price hike. Shkreli agreed to lower the price hike to a more moderate level. Surprise though, the guy never did so. Smart though, waiting for the public outrage to subside. People forget so quickly.

Being rich with nothing to do but ruin lives and count his money, Shkreli made a play on the one-off Wu-Tang Clan album, Once Upon a Time in Shaolin. The group only made one copy of the album and put it up for auction. Little did they know that Shkreli would pay $2 million for it.

According to the Wu-Tang Clan’s RZA, the $2 million deal was signed before Shkreli’s misdeeds were public knowledge. Having learned the truth, the musician has told the news agency that the bulk of the Shaolin fee will be donated to charity.

This douchebag’s just trolling at this point. If you’re gonna be hated, why not go all the way. Pretty soon Shkreli’s gonna be pushing babies out of strollers and slapping ice cream cones out of the grubby hands of innocent children.

1
Leave a Reply

avatar
1 Comment threads
0 Thread replies
0 Followers
 
Most reacted comment
Hottest comment thread
1 Comment authors
JackShepardsTheWorst Recent comment authors
  Subscribe  
newest oldest most voted
Notify of
JackShepardsTheWorst
Guest
JackShepardsTheWorst

f*ck this guy. wish odb was still around to beat the piss out of this supreme douche

Latest
Load more